Product NDC: | 0093-1022 |
Proprietary Name: | Nifediac CC |
Non Proprietary Name: | Nifedipine |
Active Ingredient(s): | 60 mg/1 & nbsp; Nifedipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-1022 |
Labeler Name: | TEVA PHARMACEUTICALS USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075269 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001207 |
Package NDC: | 0093-1022-01 |
Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-1022-01) |
NDC Code | 0093-1022-01 |
Proprietary Name | Nifediac CC |
Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-1022-01) |
Product NDC | 0093-1022 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nifedipine |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20001207 |
Marketing Category Name | ANDA |
Labeler Name | TEVA PHARMACEUTICALS USA |
Substance Name | NIFEDIPINE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |